ECSP982495A - PROTEASE INHIBITORS IV - Google Patents

PROTEASE INHIBITORS IV

Info

Publication number
ECSP982495A
ECSP982495A ECSP982495A ECSP982495A EC SP982495 A ECSP982495 A EC SP982495A EC SP982495 A ECSP982495 A EC SP982495A EC SP982495 A ECSP982495 A EC SP982495A
Authority
EC
Ecuador
Prior art keywords
alkyl
alkenyl
het
protease inhibitors
cycloalkyl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert Wells Marquis
Daniel Frank Veber
Andrew D Gribble
Ashley Edward Fenwick
Jason Witherington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982495 priority Critical patent/ECSP982495A/en
Publication of ECSP982495A publication Critical patent/ECSP982495A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Esta invención se refiere a compuestos de fórmula (I) (gráfico), en la que: R1 es R¿¿ , R¿¿C(O), R¿¿C(S), R¿¿SO2, R¿¿OC(O), R¿¿R1NC(O), o R¿¿OC(O)NR1CH(R6)C(O); R2 es H, alquilo C1-C6 alquenilo C2-C6, Ar-alquilo C0-C6 o Het-alquilo C0-C6; R3 es H, alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6, cicloalquil C3-C6 alquilo C0-C6, Ar-alquilo C0-C6, o Het-alquilo C0-C6; R4 es H, alquilo C1-C6, alquenilo C2-C6, Ar-alquilo C0-C6 o Het-alquilo C0-C6; R5 en cada caso, es independientemente H, alquilo C1-C6, alquenilo C2-C6, Ar-alquilo C0-C6; R6 es H, alquilo C1-C6, alquenilo C2-C6, cicloalquil C3-C6 alquilo C0-C6, Ar-alquilo C0-C6; o Het-alquilo C0-C6; R¿es H, alquilo C1-C6, alquenilo C2-C6 Ar-alquilo C0-C6 o Het-alquilo C0-C6; R¿¿ el alquilo C1-C6, Ar-alquilo C0-C6, Het-alquilo C0-C6, Ar-alquenilo C2-C6, o Het-alquenilo C2-C6; X es O o S; y n es 1,2 ó 3; o una de sus sales farmacéuticamente aceptables, que son inhibidores de cisteína proteasas, particularmente catepsina K, y son útiles en el tratamiento de enfermedades uno de cuyos factores es la inhibición de pérdida ósea.This invention relates to compounds of formula (I) (graph), in which: R1 is R¿¿, R¿¿ (O), R¿¿ (S), R¿¿SO2, R¿¿OC (O), R¿¿R1NC (O), or R¿¿OC (O) NR1CH (R6) C (O); R2 is H, C1-C6 alkyl, C2-C6 alkenyl, Ar-C0-C6 alkyl or Het-C0-C6 alkyl; R3 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C0-C6 alkyl, Ar-C0-C6 alkyl, or Het-C0-C6 alkyl; R4 is H, C1-C6 alkyl, C2-C6 alkenyl, Ar-C0-C6 alkyl or Het-C0-C6 alkyl; R5 in each case is independently H, C1-C6 alkyl, C2-C6 alkenyl, Ar-C0-C6 alkyl; R6 is H, C1-C6 alkyl, C2-C6 alkenyl, C3-C6 cycloalkyl, C0-C6 alkyl, Ar-C0-C6 alkyl; or Het-C0-C6-alkyl; R¿ is H, C1-C6 alkyl, C2-C6 alkenyl Ar-C0-C6 alkyl or Het-C0-C6 alkyl; R¿¿C1-C6-alkyl, Ar-C0-C6-alkyl, Het-C0-C6-alkyl, Ar-C2-C6-alkenyl, or Het-C2-C6-alkenyl; X is O or S; and n is 1,2 or 3; or one of its pharmaceutically acceptable salts, which are inhibitors of cysteine proteases, particularly cathepsin K, and are useful in the treatment of diseases one of whose factors is the inhibition of bone loss.

ECSP982495 1998-05-04 1998-05-04 PROTEASE INHIBITORS IV ECSP982495A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982495 ECSP982495A (en) 1998-05-04 1998-05-04 PROTEASE INHIBITORS IV

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982495 ECSP982495A (en) 1998-05-04 1998-05-04 PROTEASE INHIBITORS IV

Publications (1)

Publication Number Publication Date
ECSP982495A true ECSP982495A (en) 1999-01-26

Family

ID=42043416

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982495 ECSP982495A (en) 1998-05-04 1998-05-04 PROTEASE INHIBITORS IV

Country Status (1)

Country Link
EC (1) ECSP982495A (en)

Similar Documents

Publication Publication Date Title
UY24660A1 (en) PROCEDURE FOR PREPARING CYSTEINE PROTEASE INHIBITORS
NO20044207L (en) Cathepsin as cysteine protease inhibitors
ATE409482T1 (en) CATHEPSINCYSTEIN PROTEASE INHIBITORS
BR9808502A (en) Protease inhibitors
NO992492L (en) Benzamidoaldehydes and their use as cysteine protease inhibitors
MX9603775A (en) KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID 'beta'-PROTEIN PRECURSOR INHIBITOR.
SE0201976D0 (en) Novel compounds
MY116539A (en) New amino acid derivatives
ES2066033T3 (en) PROTEINASE INHIBITORS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UY25143A1 (en) PROCEDURE FOR THE PREPARATION OF PROTEASE INHIBITORS.
ATE250574T1 (en) NEW CONNECTIONS
AR021241A1 (en) PROTEASE INHIBITORS
ECSP982495A (en) PROTEASE INHIBITORS IV
AR039937A1 (en) DERIVATIVES OF AZETIDINE AS INHIBITORS OF TRIPSINE PROTEASES
SE0102921D0 (en) Pharmaceutically useful compounds
DK1311480T3 (en) Novel amidino derivatives and their use as a thrombin inhibitor
NO963469L (en) Substituted amidine derivative and aggregation blocks containing it
ECSP993211A (en) PROTEASE INHIBITORS VI
ECSP982497A (en) PROTEASE INHIBITORS V
ECSP993018A (en) NEW PROTEASE INHIBITORS, PARTICULARLY CYSTEINE AND SERINE PROTEASE INHIBITORS
BR0009944A (en) Cysteine protease and inhibitors for the prevention and treatment of neurocysticercosis
UY25369A1 (en) PROCEDURE FOR PREPARING PROTEASE INHIBITORS
JO2528B1 (en) Cathepsin cystene proteas inhibitors